Showing results (31-40 of 696) with videos related to

Sort By:
Pageof 70
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1990
Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation productsJ Amiral, M Grosley, F Mimilla, et al.
Thrombosis and Haemostasis|August 28, 2001
A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolismE Pasquier, J Amiral, L de Saint Martin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous dosesL Falkon, M Garí, M Barbanoj, et al.
Thrombosis Research|September 15, 1984
Assay of factor IX antigen using an enzyme immuno assayA Parquet-Gernez, C Mazurier, J Amiral, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1990
Reactivity of D-dimer assays with the fibrinogen--fibrin split products generated by thrombolytic agentsJ Amiral, F Minard, V Plassart, et al.
Transfusion Science|May 7, 1997
Annexin V, a new marker of platelet storage lesion: correlation with dMPVP Krailadsiri, J Seghatchian, J Amiral, et al.
Annales De Biologie Clinique|January 1, 1985
[Immunologic determination of the protein C of coagulation: detection of deficiencies]M F Aillaud, M L Olivier, J Amiral, et al.
Atherosclerosis|September 21, 2000
Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controlsA D Blann, J Amiral, C N McCollum, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1996
Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinomaB M Grosley, C Hirschauer, B Chambrette, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1996
Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell linesI Lebeurier, L Raclet, J Amiral, et al.
Pageof 70